US Cardiac Output Markets

Order Form

Report No. MSP 9906  200+ Pages 38 Tables and Figures    2000  

    

Synopsis

    Throughout the world, as developing countries create more wealth, improving the health and well-being of their citizens becomes a much higher social priority and usually leads to increased per-capita spending on health care. The world’s largest developing markets in the Pacific Rim countries and Latin America are all poised for significant economic growth, once the current financial crises abates. Based on these factors, there will be improved expansion opportunities for medical equipment suppliers who have a broad portfolio of proven cost-effective products, services and therapies to meet the demands of these markets. This shift has been slowed to a degree by the economic crisis in Asia and certain other areas of the world which manifest in 1998, and continues into 1999. It may be hampered in the immediate future by the Year 2000 (Y2K) problem. However, in the longer term, the growth of cardiac output (CO) markets is well defined and robust.

    Driven by cost, complication, and quality concerns, a shift from invasive to non-invasive technologies (where efficacy of such procedures can be demonstrated), is occurring. In cardiac output and pulmonary artery (PA) monitoring in particularly, this shift has been fueled by Dr. Conner’s famous article documenting the complications of PA catheters published in the September, 1996 issue of the JAMA

    Many new technologies are seeking to enter world markets, but in the US especially, those which succeed will be required to demonstrate not only their safety and effectiveness (to win FDA market clearance), but just as importantly their cost effectiveness compared to existing technologies they must displace. Increasingly, providers are looking for ways to better manage costs in areas such as materials handling, supply utilization, product standardization for specific procedures and capital expenditures.

    The market for invasive CO (in all its flavors) includes High Acuity OR, High Acuity ICU, and Cath Lab.The market for non-invasive CO devices is somewhat broader, encompassing Emergency Departments, Birthing Rooms, and other clinical settings. Transitions from invasive to non-invasive are occurring in all of the above areas.While thermal dilution approaches have displaced dye dilution in some segments, the technology has evolved beyond thermal dilution CO (tdCO) to CCO, SvO2, and non-invasive approaches. Some of these technologies are substantially more expensive then those they seek to displace. Not all of these technologies have been embraced in the evolving managed care environment.

    This reports looks at both invasive and non-invasive cardiac output technologies and discusses factors limiting the emergence of newer technologies. It snapshots the US market in 1996 for invasive and non-invasive but does NOT contain 5 year projections of the market. It will be useful however to those seeking a better understanding of all available technologies, and how the newer non-invasive technologies are poised to emerge.

 

 
Order Form

Download Brochure & Outline

Download Report Summary

                                                                                           

 
Home Page
Consulting
What's New?
Complete List of Publications
 
About The Company
About The Principals

 WinterGreen Research, Inc

6 Raymond St
Lexington, MA 02173
Tel: 781-863-5078
Fax: 781-863-1235
© 1999 WinterGreen Research, Inc. All Rights Reserved.